Skip to main content

Table 5 Comparison of metabolites concentrations and enzyme activities based on fatty acid ratios between the final and the baseline status (Final vs. Baseline) in group 3 (meeting the NAFLD criteria at baseline but not meeting them during the follow-up)

From: Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

Metabolites and enzyme activities

Paired Student’s t-test (p-value)

log2 (fold change)

Steroids

1.99E-02

−0.46

Saturated fatty acids

1.36E-02

−0.30

1-Monoacylglycerophosphocholine

2.15E-03

−0.27

2-Monoacylglycerophosphocholine

2.85E-02

−0.16

Monoacylglycerophosphocholine

1.16E-02

−0.20

Lysophosphatidylcholines

1.49E-02

−0.17

1-Monoacylglycerophosphoethanolamine

1.23E-02

−0.23

MonoetherglycerophosphoethanolaminesO_plasmanyles

2.12E-02

−0.32

Phospholipase-A2 (LPC/PC)

8.38E-03

−0.28

Phospholipase-A2 (LPE/PE)

1.91E-02

−0.21

(NEFA) n-6/n-3

1.15E-02

0.57

De novo lipogenesis (16:0/18:2n-6)

8.49E-04

−0.43

Stearoyl-CoA desaturase 1 (18:1n-9/18:0)

2.35E-04

−0.58

Elongase-6 (18:0/16:0)

6.78E-05

0.71

Delta-6- desaturase (18:3n-6/18:2n-6)

4.65E-04

−0.63

Delta-6- desaturase (18:3/18:2)

2.43E-04

−0.55

Stearoyl-CoA desaturase 1 (16:1n-7/16:0)

3.22E-03

0.11

18:1/18:0

3.65E-04

−0.21

Lecithin:cholesterolacyltransferase (ChoE/Chol)

2.64E-02

0.47

  1. log2 (fold-change) and p-values follows the criterion of heatmap figure
  2. Abbreviations: LPC lysophosphatidylcholine, LPE lysophosphatidylethanolamine, NEFA non esterified fatty acids, ChoE cholesteryl esters, Chol cholesterol